Abstract
Ninety-two 18fluoro-deoxy-D-glucose (FDG) PET examinations performed on oncological patients yielded conclusive results for primary diagnostics, staging, restaging and therapeutic monitoring in 39%, 85%, 82% and 93% of the cases, respectively. The 77% overall incidence of conclusive results indicates that the FDG PET technique is a powerful clinical tool. It should be emphasized that this result was attained through careful histopathological investigations, high-resolution anatomic imaging procedures and an active follow-up policy. Additional information was obtained concerning the proliferative capacity of the tumour cells and the extent of the viable tumorous tissue. The metabolically-based determination of the tumour margins by PET and CT-MRI-PET image fusion helped in delineation of the gross tumour volume and its subclinical extent for three-dimensional (3D) radiotherapy planning ensuring a more adequate dose coverage. The value of FDG PET investigations in oncology may be summarized as follows: limited in the primary diagnostics, strong in staging and restaging, very strong in therapeutic monitoring, and investigational in estimations of the proliferative capacity of tumorous tissue and 3D radiation treatment planning.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adler, L.P., Crowe, J.P., Al-Kaisi, N.K. and Sunshine, J. (1993) Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET, Radiology 187,743–750.
Ágoston, P., Ésik, O., Gulyás, B., Boros, I., Forrai, G. and Trón, L. (1996) Whole-body PET in the search for unknown primary tumours and restaging of cancer patients after treatment, Radiother. Oncol . 40, Suppl (1) S141.
Bendl, R., Pross, J., Hoess, A, Keller, MA, Preiser, K. and Schlegel, W. (1994) VIRTUOS - A program for VIRTUal RadiOtherapy Simulation and verification, in A.R. Hounsell, J.M. Wilkinson and P.C. Williams (eds.), Proceedings of the 11th International Conference on the Use of Computers in Radiation Therapy, Manchester, pp. 226–227.
Crowe, J.P. Jr., Adler, L.P., Shenk, R.R. and Sunshine, J. (1994) Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings, Ann. Surg. Oncol. 1, 132–140.
Dobbs, H.J., Parker, R.P., Hodson, N.J., Hobday, P. and Husband, J.E. (1983) The use of CT in radiotherapy treatment planning, Radiother. Oncol. 1,133–142.
Emri, M., Márián, T., Kövér, G., Berényi, E. and Ésik, O. (1996) Registration: a powerful tool to combine information by different imaging modalities, in B. Gulyas and H.W. Müller-Gärtner (eds.), Positron emission tomography: a critical assessment of recent trends, Kluwer Academic Publishers, Dordrecht, this volume.
Engel, H., Steinert, H., Buck, A., Berthold, T., Huch Boni, R.A. and von Schulthess, K. (1996) Whole-body PET: physiological and artifactual fluorodeoxyglucose accumutations, J. Nucl. Med. 37,441–446.
Ésik, O., Márián, T., Gulyás, B., Tóth, E., Lövey, J. and Trón, L. (1996) FDG PET investigation in medullary thyroid cancer, in A.M.J. Pawns, J. Pruim, E.J.F. Franssen and W. Vaalburg (eds.), Proceedings of the European Conference on Research and Application ofPositron Emission Tomography in Oncology, Groningen, p. 137.
Gupta, N.C., Maloof, M. and Gunel, E. (1996) Probability of malignancy in solitary pulmonary nodules using flourine-18-FDG and PET, J. Nucl. Med. 37,943–948.
Haberkorn, U., Strauss, L.G., Reisser, C., Haag, D., Dimitrakopoulou, A., Ziegler, S., Oberdorfer, F., Rudat, V. and van Kaick, G. (1991) Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry, J. Nucl. Med. 32, 1548–1555.
Hoh, C.K., Hawkins, R.A., Glaspy, J.A., Dahlbom, M., Tse, N.Y., Hoffman, E.J., Schiepers, C., Choi, Y., Rege, S., Nitzsche, E., Maddahi, J. and Phelps, M.E. (1993) Cancer detection with whole-body PET using 2[18F]fluoro-2-deoxy-D-glucose, J. Comput. Assist. Tomogr. 17, 582–589.
Kole, A.C., Nieweg, O.E., Vermey, A, Braams, J.W., Pruim, J., Hoekstra, H.J., Roodenburg, J.L.N., Schraffordt Koops, H. and Vaalburg W. (1996) Detection of unknown primary tumors using whole body PET with 18FDG, in A.M.J. Paans, J. Pruim, E.J.F. Franssen and W. Vaalburg (eds.), Proceedings of the European Conference on Research and Application of Positron Emission Tomography in Oncology, Groningen, p. 135–136.
Leskinen-Kallio, S., Năgren, K., Lehikoinen, P., Routsalainen, U. and Joensuu H. (1991) Uptake of 11Cmethionine in breast cancer studied by PET. An association with the size of S-phase fraction, Br. J. Cancer 64, 1121–1124.
Levin, D.N., Pelizzari, C.A., Chen, G.T.Y., Chen, C.-T. and Cooper, M.D. (1988) Retrospective geometric correlation of MR, CT, and PET images, Radiology 169, 817–823.
Lövey, J., Ésik, O., Gulyás, B., Tóth, E., Molnár, T. and Trón, L. (1996) FDG PET for the evaluation of metastatic lymph nodes, in B. Gutyâs and H.W. Müller-GArtner (eds.), Positron emission tomography: a critical assessment of recent trends, Kluwer Academic Publishers, Dordrecht, this volume.
Lynch, H.T., Smyrk, T.C., Watson, P., Lanspa, S.J., Lynch, J.F., Lynch, P.M., Cavalieri, R.J. and Boland, C.R. (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review, Gastroenterology 104, 1535–1549.
March, D.E., Wechsler, R.J., Kurtz, AB., Rosenberg, AL. and Needleman, L. (1991) CT-pathologic correlation of axillary lymph nodes in breast carcinoma, J. Comput. Assist. Tomogr. 15, 440–444.
Minn, H., Joensuu, H., Ahonen, A., Klemi, P. (1988) Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors, Cancer 61, 1776–1781.
Miyazawa, H., Arai, T., Iio, M. and Hara, T. (1993) PET imaging of non-smal-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters, J. Nucl. Med. 34,1886–1891.
Nieweg, O.E., Kim, E.E., Wong, W.-H., Brousssard, W.F., Singletary, S.E., Hortobagyi, G.N. and Tilbury, R.S. (1993) Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer, Cancer 71, 3920–3925.
Nolop, K.B., Rhodes, C.G., Brudin, L.H., Beaney, R.P., Krauss, T., Jones, T. and Hughes, J.M.B. (1987) Glucose utilization in vivo by human pulmonary neoplasms, Cancer 60, 2682–2689.
Pelizzari, CA., Chen, G.T.Y., Halpern, H., Chen, C.-T. and Cooper, M.D. (1987) Three-dimensional correlation of PET, CT and MRI images, J. Nucl. Med. 28, 682.
Pross, J., Bendl, R. and Schlegel, W. (1994) TOMAS, a TOol for MAnual Segmentation based on multiple image data sets, in A.R. Hounsell, J.M. Wilkinson and P.C. Williams (eds.), Proceedings of the 11th International Conference on the Use of Computers in Radiation Therapy, Manchester, pp.192–193.
Reisser, C., Haberkom, U. and Strauss, L.G. (1993) The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors, J. Otolaryngol. (Canada) 22, 231–238.
Shad, L.R., Boesecke, R., Schlegel, W., Hartmann, G.H., Sturm, V., Strauss, L.G. and Lorenz, W.J. (1987) Three dimensional image correlation of CT, MR, and PET studies in radiotherapy treatment planning of brain tumors, J. Comput. Assist. Tomogr. 11, 948–954.
Shuman, W.P., Griffin, B.R, Haynor, D.R., Johnson, J.S., Jones, D.C., Cromwell, L.D. and Moss, A.A. (1985) MRI imaging in radiation therapy planning, Radiology 156,143–147.
Szakáll, S. Jr., Trón, L., Gulyás, B. and Ésik, O. (1996) FDG-PET in the follow-up of patients with differentiated thyroid cancer, Radiother. Oncol. 40, Suppl (1) S 140.
Székely, J., Poller, I., Gulyás, B., Balkay, L., Trón, L. and Ésik, O. (1996) PET in the follow-up of CNS tumours after radiotherapy, Radiother. Oncol. 40, Suppl (1) S 140.
Szentirmay, Z., Tusnády, G. and Tóth, E. (1997) A daganatok kóros DNS tartalma [Cellular DNA content of human tumours, in Hungarian], Orvosi Hetilap 138, 000–000.
Tse, N.Y., Hoh, C.K., Hawkins, R.A., Zinner, M.J., Dahlbom, M., Choi, Y., Maddahi, J., Brunicardi C., Phelps M.E. and Glaspy, J.A. (1992) The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease, Ann. Surg. 216, 27–34.
Wahl, R.L., Cody, R.L., Hutchins, G.D. and Mudgett, E.E. (1991) Primary and metastatic breast carcinoma: initial clinical evaluation with PET and the radiolabeled glucose analog 2-[F-18]-fluoro-2-deoxy-D-glucose, Radiology 179, 765–770.
Wahl, R.L., Quint, L.E., Cieslak, R.D., Aisen, A.M., Koeppe, R.A. and Meyer, C.R. (1993) “Anatometabolic” tumor imaging fusion of FDG PET with CT or MRI to localize foci of increased activity, J. Nucl. Med. 34, 1190–1197.
Woods, R.P., Mazziotta, J.C. and Cherry, S.R. (1993) MRI-PET registration with automated algorithm, J. Comput. Assist. Tomogr. 17, 536–546.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ésik, O., Gulyás, B., Trón, L. (1998). Diagnosis, Differential Diagnosis, and Follow-Up of Tumours by Means of FDG PET. In: Gulyás, B., Müller-Gärtner, H.W. (eds) Positron Emission Tomography: A Critical Assessment of Recent Trends. NATO ASI Series, vol 51. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4996-9_16
Download citation
DOI: https://doi.org/10.1007/978-94-011-4996-9_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6097-4
Online ISBN: 978-94-011-4996-9
eBook Packages: Springer Book Archive